Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01610804|
Recruitment Status : Completed
First Posted : June 4, 2012
Last Update Posted : June 4, 2012
The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).
Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||18 participants|
|Official Title:||Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||November 2011|
|Actual Study Completion Date :||May 2012|
Patients suffering from Central Serous Chorioretinopathy
Healthy subjects with (assumed) normal choroidal thickness
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01610804
|University Hospital Regensburg|
|Regensburg, Bavaria, Germany, 93053|
|Study Chair:||Maria A Gamulescu, PD Dr. med.||University Hospital Regensburg|